Related Posts:
FDA Draft Guidance - Drug Supply Chain and SNIs
FDA - Global Drug Supply Chain Needs Better Oversight
Prescription Drug Reimportation and Safety - Both Presidential Candidates Support It
Return Home: http://drughealth.blogspot.com/
Thoughts and resources about health, drugs and prescriptions, and how they are affected by GMPs (FDA Good Manufacturing Practices) and other regulations.
▼
Wednesday, February 25, 2009
Foreign Pharma Inspection Trends - Burdensome
"In today's global marketplace, a single manufacturing site may supply more than 80 markets and spend as many as 137 days working on one inspection, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA)," reports this PharmTech.com article, Trends In: Foreign Inspections. It turns out that the most active inspectorates in order of activity reported are those from the European Union, United States, Brazil, Japan, Mexico, South Korea, and Uganda.
Are foreign inspections eating your lunch?! If so, how can we transform current practice into a better solution to assuring compliance? Perhaps joint inspections?!
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.